Associate Professor of Surgery
General Surgery
Dr. John H. Yim, MD
|
|
Give Review
John H. Yim practices General Surgery. He graduated from Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He has 1 awards "Fellow (FACS)". John H. Yim is also a published doctor. He has 60 publication published. The most recent publication is: Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1.
Publications
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer.
- Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in Cancer cells.
- Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast Cancers after anthracycline-free neoadjuvant chemotherapy wi...
- Life Expectancy after Curative-intent Treatment of Breast Cancer: Impact on Long-term Follow-up Care.
- Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast Cancer.
- Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in Cancer cells.
- Identification of a Natural Compound by Cell-Based Screening that Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression.
- Thyroid surgery and surgeons: the common interest.
- The adrenal mass: correlation of histopathology with imaging.
- Optimizing surgical treatment of papillary thyroid Carcinoma associated with BRAF mutation.
- Sestamibi SPECT intensity scoring system in sporadic primary hyperParathyroidism.
- Localization of Parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive Parathyroidecto...
- Cystic Parathyroid lesions: functional and nonfunctional Parathyroid cysts.
- Tumor-to-tumor metastases to follicular variant of papillary thyroid Carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases.
- Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlations.
- Loss of heterozygosity of selected tumor suppressor genes in parathyroid Carcinoma.
- Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperParathyroidism.
- Can a lightbulb sestamibi SPECT accurately predict single-gland Disease in sporadic primary hyperparathyroidism?
- Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid Cancer.
- The incidence of Cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
- Recurrent hyperParathyroidism secondary to parathyromatosis: clinical and imaging findings.
- Pathology quiz case 2. Parathyroid lipoadenoma.
- Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors.
- The transcription factor interferon regulatory factor-1 mediates Liver damage during ischemia-reperfusion injury.
- Hyperthyroidism after Parathyroid exploration.
- Allelic loss in Parathyroid neoplasia can help characterize malignancy.
- Ectopic expression of interferon regulatory factor-1 promotes human breast Cancer cell death and results in reduced expression of survivin.
- Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
- The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human Breast carcinoma cell lines.
- Elevated serum parathormone level after "concise Parathyroidectomy" for primary sporadic hyperParathyroidism.
- Involvement of retinoblastoma protein in p27Kip1-induced apoptosis.
- Cloning and structure of a rabbit protein inhibitor of neuronal nitric oxide synthase (PIN) gene and its pseudogene.
- In vivo and in vitro Analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
- The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated Cell death.
- The binding of two dimers of IciA protein to the dnaA promoter 1P element enhances the binding of RNA polymerase to the dnaA promoter 1P.
- Human cytomegalovirus IE1 protein activates AP-1 through a Cellular protein kinase(s).
- Unusual presentation of solitary cutaneous myxoma.
- High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
- The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.
- Epithelial Cell-specific laminin 5 is required for survival of early thymocytes.
- Signaling pathways to the assembly of an interferon-beta enhanceosome. Chemical genetic studies with a small molecule.
- Identification of Mad as a repressor of the human telomerase (hTERT) gene.
- Molecular characterization of Drosophila melanogaster dihydropteridine reductase.
- Molecular characterization of Drosophila melanogaster myo-inositol-1-phosphate synthase.
- Activation of interferon regulatory factor 3 in response to DNA-damaging agents.
- Mammographically detected breast Cancer. Benefits of stereotactic core versus wire localization biopsy.
- Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.
- Underlying pathology in mammary Paget's Disease.
- Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway.
- IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the Malignant phenotype and enhances immunogenicity in syngeneic mice.
- Papillary thyroid Cancer.
- Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1.
- Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma.
- Appropriate surgical treatment of lithium-associated hyperParathyroidism.
- IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in Cancer cells.
- Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast Cancer cells.
- IFN-gamma enhances TRAIL-induced apoptosis through IRF-1.
- IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary Cancer cells in vitro and in vivo.
- Ad-IRF-1 induces apoptosis in esophageal adenoCarcinoma.
Schools
Stanford University School Of Medicine
BarnesJewish Hospital Washington University
National Institutes Of Health
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Washington University -
Stanford University School of Medicine
Hospital
-
City of Hope's Helford Clinical Research Hospital
Drug Facts
| NPI NUMBER | 1598731820 | |
| NPPES Provider LastName | YIM | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 910103012 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 58.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598731820 |
| Last Name Of The Provider | YIM |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Kevin G. Chan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yih-Dar Nien Shy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Byrne Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lily Lai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Kim, MD |
|
Dr. Behnam B. Badie, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gagandeep P. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eduardo A. Guzman, MD |
|
|
Dr. Mark Kawachi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vijay Trisal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lesley A. Taylor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura Kruper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shaila J. Merchant, MD
This Doctor is OpenDoctor Recommended.
|